Haemonetics Corporation Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value
Haemonetics Corporation (HAE) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value of $7.41 per share for the 9-month period ending 2015-12-26, per its 10-Q filed 2016-02-02.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue · last filed 2016-02-02
- Haemonetics Corporation share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2015-06-27 was $9.98, a 33.24% increase year-over-year.
- Haemonetics Corporation share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2014-06-28 was $7.49, a 23.42% decline year-over-year.
- Haemonetics Corporation share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2013-06-29 was $9.78, a 12.67% increase year-over-year.
- Haemonetics Corporation share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2012-06-30 was $8.68, a 50.90% decline year-over-year.
- Haemonetics Corporation share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2012 was $16.31, a 3.03% increase from fiscal 2011.
- Haemonetics Corporation share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2011 was $15.83, a 2.99% increase from fiscal 2010.
- Haemonetics Corporation share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2010 was $15.37.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 3 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 6 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 9 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 12 month |
|---|---|---|---|---|---|---|---|
| 2015-12-26 | $7.41 10-Q · filed 2016-02-02 | ||||||
| 2015-09-26 | $9.05 10-Q · filed 2015-11-04 | ||||||
| 2015-06-27 | $9.98 10-Q · filed 2015-07-30 | ||||||
| 2014-12-27 | $7.89 10-Q · filed 2016-02-02 | ||||||
| 2014-09-27 | $8.08 10-Q · filed 2015-11-04 | ||||||
| 2014-06-28 | $7.49 10-Q · filed 2015-07-30 | ||||||
| 2013-12-28 | $10.17 10-Q · filed 2015-02-05 | ||||||
| 2013-09-28 | $10.98 10-Q · filed 2013-10-30 | ||||||
| 2013-06-29 | $9.78 10-Q · filed 2014-07-31 | ||||||
| 2012-12-29 | $9.76 10-Q · filed 2014-01-30 | ||||||
| 2012-09-29 | $9.01 10-Q · filed 2013-10-30 | $18.02 10-Q · filed 2012-11-07 | |||||
| 2012-06-30 | $8.68 10-Q · filed 2013-08-02 | $17.36 10-Q · filed 2012-08-08 | |||||
| 2012-03-31 | $16.31 10-K · filed 2012-05-22 | ||||||
| 2011-12-31 | $8.15 10-Q · filed 2013-02-01 | $16.29 10-Q · filed 2012-02-06 | |||||
| 2011-10-01 | $18.27 10-Q · filed 2012-11-07 | ||||||
| 2011-07-02 | $17.68 10-Q · filed 2012-08-08 | ||||||
| 2011-04-02 | $15.83 10-K · filed 2012-05-22 | ||||||
| 2011-01-01 | $15.63 10-Q · filed 2012-02-06 | ||||||
| 2010-10-02 | $16.89 10-Q · filed 2011-11-03 | ||||||
| 2010-07-03 | $17.48 10-Q · filed 2011-08-10 | ||||||
| 2010-04-03 | $15.37 10-K · filed 2012-05-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| PULSE BIOSCIENCES, INC. (PLSE) | United States | $3.696B | -24.47 |
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |